Barclays
MENS

Barclays’s Jyong Biotech MENS Stock Holding History

Barclays’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.3K Buy
5,931
+742
+14% +$1.57K ﹤0.01% 4672
2026
Q1 		$11.2K Buy
5,189
+1,649
+47% +$4.03K ﹤0.01% 4680
2025
Q4 		$14K Buy
+3,540
New +$125K ﹤0.01% 4908

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays's MENS Position: Q2 2026 in Review

Barclays increased its Jyong Biotech (MENS) stake by 14% in Q2 2026, buying an estimated $1.57K and bringing the position to 5,931 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4672.

Barclays first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $14K in Q4 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Barclays held 5,931 shares of Jyong Biotech worth $12.3K as of Q2 2026.
  • Barclays bought 742 Jyong Biotech shares in Q2 2026, an estimated $1.57K.
  • Jyong Biotech made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4672 holding.
  • Barclays first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • Barclays's Jyong Biotech position peaked at $14K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.